Literature DB >> 12447045

The vascular supply of the extended tensor fasciae latae flap: how far can the skin paddle extend?

Arun K Gosain1, Ji-Geng Yan, Mustafa A Aydin, Dilip K Das, James R Sanger.   

Abstract

The vascular supply of the tensor fasciae latae flap and of the lateral thigh skin was studied in 10 cadavers to evaluate whether the lateral thigh skin toward the knee could be incorporated into an extended tensor fasciae latae flap. Within each cadaver, vascular injection of radiopaque material preceded flap elevation in one limb and followed flap elevation in the contralateral limb. Flaps raised after vascular injection were examined radiographically to evaluate the vascular anatomy of the lateral thigh skin independent of flap elevation. When vascular injection was made into the profunda femoris, the upper two-thirds of the flaps was better visualized than the distal third. When the injection was made into the popliteal artery, the vasculature of the distal third of the flaps was better visualized. Flaps raised before vascular injection were examined radiographically to delineate the anatomical territory of the vascular pedicle that had been injected. In these flaps, consistent cutaneous vascular supply was only seen in the skin overlying the tensor fasciae latae muscle, confirming that musculocutaneous perforators are the predominant means by which the pedicle of the tensor fasciae latae flap supplies the skin of the lateral thigh. Extended tensor fasciae latae flaps were elevated bilaterally in one cadaver, and selective methylene blue injections were made into the lateral circumflex femoral artery on one side and into the superior lateral genicular artery on the contralateral side. Methylene blue was observed in the proximal and distal thirds of the skin paddles, respectively, leaving unstained midzones. The vascular network of the lateral thigh skin could be divided into three zones. The lateral circumflex femoral artery and the third perforating branches of the profunda femoris artery perfuse the proximal and middle zones of the lateral thigh skin, respectively. The superior lateral genicular artery branch of the popliteal artery perfuses the distal zone. The middle and distal zones meet 8 to 10 cm above the knee joint, where the skin paddle of the tensor fasciae latae flap becomes unreliable. These data indicate that if the aim is to incorporate the skin over the distal thigh in an extended tensor fasciae latae flap without resorting to free-tissue transfer, then either a carefully planned delay procedure or an additional anastomosis to the superior lateral genicular artery is required.

Entities:  

Mesh:

Year:  2002        PMID: 12447045     DOI: 10.1097/01.PRS.0000033023.09635.B4

Source DB:  PubMed          Journal:  Plast Reconstr Surg        ISSN: 0032-1052            Impact factor:   4.730


  5 in total

1.  Morel-Lavallee lesion in an adolescent with ultrasound and MRI correlation.

Authors:  Kausik Mukherjee; Sarah M Perrin; Phil M Hughes
Journal:  Skeletal Radiol       Date:  2006-06-22       Impact factor: 2.199

Review 2.  The Morel-Lavallée lesion: pathophysiology, clinical presentation, imaging features, and treatment options.

Authors:  Iris Bonilla-Yoon; Sulabha Masih; Dakshesh B Patel; Eric A White; Benjamin D Levine; Kira Chow; Christopher J Gottsegen; George R Matcuk
Journal:  Emerg Radiol       Date:  2013-08-16

3.  Clinical experience using a tensor fascia lata flap in oncology patients.

Authors:  Akira Saito; Hidehiko Minakawa; Noriko Saito; Kazuo Isu; Hiroaki Hiraga; Toshihisa Osanai
Journal:  Surg Today       Date:  2013-09-25       Impact factor: 2.549

4.  The vascularized fascia lata free flap: an anatomical study and clinical considerations.

Authors:  Stefan Janik; Lena Hirtler; Hannes Traxler; Wolfgang J Weninger; Rudolf Seemann; Boban M Erovic
Journal:  Eur Arch Otorhinolaryngol       Date:  2020-02-25       Impact factor: 2.503

Review 5.  Reconstruction for lower extremity limb salvage in soft tissue carcinoma.

Authors:  Neal S Topham
Journal:  Curr Treat Options Oncol       Date:  2003-12
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.